Search Results - Paul L. Prather

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Cover Image

    Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N‐(adamantan‐1‐yl)‐1‐(5‐fluoropentyl)‐1H‐indole‐3‐carboxamide (STS‐135) by Sabrina Jones, Azure L. Yarbrough, William E. Fantegrossi, Paul L. Prather, John M. Bush, Anna Radominska‐Pandya, Ryoichi Fujiwara

    Published 2020
    Connect to this object online.
    Book

    Save to List
    Saved in:
  2. 2
    Cover Image

    Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats by Venumadhav Janganati, Paloma Salazar, Brian J. Parks, Gregory S. Gorman, Paul L. Prather, Eric C. Peterson, Alexander W. Alund, Jeffery H. Moran, Jeffery H. Moran, Peter A. Crooks, Lisa K. Brents

    Published 2023
    Connect to this object online.
    Book

    Save to List
    Saved in:
  3. 3
    Cover Image

    Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ9-THC by Rachel D. Hutchison, Benjamin M. Ford, Lirit N. Franks, Catheryn D. Wilson, Azure L. Yarbrough, Ryoichi Fujiwara, Mark K. Su, Denise Fernandez, Laura P. James, Jeffery H. Moran, Amy L. Patton, William E. Fantegrossi, Anna Radominska-Pandya, Paul L. Prather

    Published 2018
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: